Showing posts with label Adults. Show all posts
Showing posts with label Adults. Show all posts
Friday, September 30, 2022

FDA Approves Auvelity (dextromethorphan and bupropion) for the Treatment of Major Depressive Disorder in Adults

›
            dextromethorphan   Bupropion In continuation of my updates on dextromethorphan and Bupropion ,  Axsome Therapeutics, Inc. , a...
Wednesday, March 9, 2022

FDA Approves Quviviq (daridorexant) for the Treatment of Adults with Insomnia

›
Idorsia Ltd (SIX: IDIA) announced  the US Food and Drug Administration (FDA)  approval of   Quviviq  (daridorexant) 25 mg and 50 mg for the ...
Monday, March 7, 2022

FDA Approves Cibinqo (abrocitinib) for Adults with Moderate-to-Severe Atopic Dermatitis

›
Pfizer Inc. (NYSE: PFE) announced  the United States (U.S.) Food and Drug Administration (FDA) approval of   Cibinqo  (abrocitinib), an oral...
Thursday, January 14, 2021

FDA Approves Onureg (azacitidine tablets) as Continued Treatment for Adults in First Remission with Acute Myeloid Leukemia

›
Bristol Myers Squibb (NYSE: BMY) announced that the U.S. Food and Drug Administration (FDA) has approved  Onureg  (azacitidine 300 mg tablet...
Saturday, March 21, 2020

FDA Approves Turalio (pexidartinib) for the Treatment of Symptomatic Tenosynovial Giant Cell Tumors (TGCT) in Adults

›
In continuation of my update on pexidartinib U.S. Food and Drug Administration granted approval to  Turalio  (pexidartinib) caps...
Friday, March 20, 2020

FDA Approves Rybelsus (semaglutide), the First Oral GLP-1 Analog Treatment for Adults with Type 2 Diabetes

›
In continuation of my updates on Semaglutide Novo Nordisk today announced that the U.S. Food and Drug Administration (FDA) has appro...
Tuesday, January 7, 2020

FDA Approves Turalio (pexidartinib) for the Treatment of Symptomatic Tenosynovial Giant Cell Tumors (TGCT) in Adults

›
U.S. Food and Drug Administration granted approval to Turalio (pexidartinib) capsules for the treatment of adult patients with symptom...
Tuesday, October 23, 2018

FDA Approves Perseris (risperidone) for Extended-Release Injectable Suspension for the Treatment of Schizophrenia in Adults

›
In continuation of my update on  risperidone Indivior PLC,   announced that the U.S. Food and Drug Administration (FDA) has approved...
Friday, October 19, 2018

FDA Approves Mulpleta (lusutrombopag) for Thrombocytopenia in Adults with Chronic Liver Disease

›
FDA, approved lusutrombopag (Mulpleta, Shionogi Inc.) for thrombocytopenia in adults with chronic liver disease who are scheduled to under...